MEDIT SA is a privately held software development and contract research company incorporated in May 2003 and operating in the Saclay Scientipole area, France, an outstanding place for science and innovation. MEDIT SA is focused on a powerful approach to Drug Design with their core technology: MED-SuMo. A new, rapid and accurate approach to structure based drug design is offered to molecular modellers and medicinal chemists.